Insider Shareholders with Direct Ownership of Calithera Biosciences, Inc. (CALA)
This section provides a comprehensive overview of the insiders with direct ownership of Calithera Biosciences, Inc. (CALA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Calithera Biosciences, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Bvf Partners L P
> 10% Shareholder |
2,716,927 | 2,283,598 | 480,432 $0 | 5 |
May 21, 2020
Reduced 28.58%
|
Jonathan G Drachman
Director |
200,000 | 0 | 200,000 $0 | 1 |
Nov 10, 2021
Added 50.0%
|
Francesco Parlati
SR. VP, RESEARCH |
180,000 | 84,402 | 140,998 $0 | 7 |
Jan 21, 2022
Reduced 3.29%
|
Sumita Ray
Officer |
90,000 | 0 | 105,000 $0 | 3 |
Nov 05, 2021
Added 10.26%
|
Christopher Molineaux
SR. VP, DEVELOPMENT |
90,000 | 0 | 102,500 $0 | 3 |
Nov 05, 2021
Added 10.48%
|
Susan Molineaux
PRESIDENT & CEO |
85,000 | 0 | 95,000 $0 | 1 |
Jan 20, 2021
Added 47.22%
|
Curtis Hecht
CHIEF BUSINESS OFFICER |
65,000 | 0 | 92,321 $0 | 1 |
Jan 20, 2021
Added 24.53%
|
Keith Orford
Director |
185,000 | 132,447 | 66,094 $0 | 7 |
Nov 11, 2021
Reduced 42.17%
|
Eric Sjogren
SR. VP, DRUG DISCOVERY |
180,000 | 84,681 | 8,467 $0 | 8 |
Jan 23, 2023
Reduced 3.19%
|
Stephanie Wong
Officer |
185,000 | 85,511 | 6,287 $0 | 8 |
Jan 23, 2023
Reduced 4.8%
|
Emil Kuriakose
CHIEF MEDICAL OFFICER |
12,000 | 7,677 | 3,539 $0 | 5 |
Jan 23, 2023
Reduced 2.18%
|